Global Blood Plasma Derivatives Market Projected to Grow at 9.4% CAGR, Reaching $80.42 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Blood Plasma Derivatives Industry Market Size Be by 2025?
The size of the blood plasma derivatives market has seen significant expansion in the past few years. From $51.81 billion in 2024, it's projected to increase to $56.24 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The past market expansion could be credited to a rise in incidents of hemophilia and other bleeding disorders, an aging population, heightened awareness and detection, an increase in surgical procedures, and the global expansion of blood transfusion services.

What's the Long-Term Growth Forecast for the Blood Plasma Derivatives Market Size Through 2029?
Expectations are high for the blood plasma derivatives market to experience substantial growth in the coming years. The projection is a surge reaching $80.42 billion by 2029, increasing at a compound annual growth rate (CAGR) of 9.4%. The upswing forecasted for the period is mainly owed to the rise of treatments for rare diseases, the prevalence of chronic diseases, heightened healthcare spending, patient-oriented treatment methodologies, and the expansion of the healthcare infrastructure. The key trends predicted for the forecast period encompass improvements in fractionation technologies, patient-centered strategies, forming collaborations and partnerships, the widening of applications in the field of neurology, and technological advancements in plasma fractionation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

What Are the Key Growth Drivers Fueling the Blood Plasma Derivatives Market Expansion?
The escalation in the instances of immunodeficiency disorders is anticipated to propel the blood plasma derivatives market's expansion. These disorders could either completely or partially impair the immune system. The application of blood plasma derivatives is significant in the treatment of numerous medical conditions, especially immune deficiency disorders. Plasma, incorporating over 100 distinct proteins in a solution with salts, particularly utilizes immunoglobulins to treat primary immunodeficiencies. Inadequate or poor nourishment can result in both macro and micronutrient deficiencies, potentially leading to immunodeficiency. For example, data published by the Allergy, Asthma & Clinical Immunology in March 2022 indicated that the most widespread condition was Common Variable Immunodeficiency (CVID) which affected 16.6% of US individuals, 12.9% internationally, and 13.9% globally. As a result, the ongoing escalation in the instances of immune deficiency disorders supports the expansion of the blood plasma derivatives market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What Are the Key Trends Driving Blood Plasma Derivatives Market Growth?
Key players in the blood plasma derivatives market are leveraging strategic partnerships to maintain a competitive position. Through these alliances, patients requiring vital plasma-derived medication will receive a consistent and reliable supply, addressing the growing demand for immunoglobulins not just in France, but globally. An example is the January 2022 collaboration between Italy's Kedrion S.p.A., a biopharmaceutical firm focusing on the creation, manufacturing, and distribution of plasma-based therapies, and LPB, a UK firm dealing with biological medicinal products. Kedrion will utilize LFB plasma, sourced from France by Etablissement Français du Sang (EFS), to manufacture immunoglobulins in Hungary. This will supplement the current immunoglobulin supply, overseen by French health authorities, and will be made available to hospitals nationwide, thanks to LFB imports from France.

How Is the Blood Plasma Derivatives Market Segmented?
The blood plasma derivatives market covered in this report is segmented -

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:
1) By Albumin: Human Serum Albumin, Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin
6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Which Companies Are Leading the Charge in Blood Plasma Derivatives Market Innovation?
Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Which Regions Are Leading the Global Blood Plasma Derivatives Market in Revenue?
North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.